1 |
negative regulation of cell population proliferation |
GO:0008285 |
10.16 |
MIR93 MIR9-1 MIR221 MIR21 MIR15A APC |
2 |
miRNA-mediated gene silencing |
GO:0035195 |
10.1 |
MIR126 MIR139 MIR142 MIR143 MIR144 MIR145 |
3 |
positive regulation of angiogenesis |
GO:0045766 |
9.92 |
MIR31 MIR21 MIR199A1 MIR143 MIR126 |
4 |
negative regulation of angiogenesis |
GO:0016525 |
9.91 |
MIR21 MIR15A MIR145 MIR143 |
5 |
negative regulation of gene expression |
GO:0010629 |
9.91 |
MIR93 MIR9-1 MIR21 MIR199A1 MIR17 MIR155 |
6 |
positive regulation of protein kinase B signaling |
GO:0051897 |
9.85 |
MIR221 MIR21 MIR199A1 MIR143 MIR126 |
7 |
negative regulation of osteoblast differentiation |
GO:0045668 |
9.82 |
MIR93 MIR9-1 MIR17 |
8 |
positive regulation of vascular associated smooth muscle cell proliferation |
GO:1904707 |
9.82 |
MIR221 MIR21 MIR17 |
9 |
negative regulation of cell migration |
GO:0030336 |
9.8 |
MIR93 MIR9-1 MIR31 MIR21 MIR145 MIR126 |
10 |
negative regulation of cardiac muscle cell apoptotic process |
GO:0010667 |
9.77 |
MIR21 MIR199A1 MIR145 |
11 |
positive regulation of blood vessel endothelial cell migration |
GO:0043536 |
9.73 |
MIR126 MIR143 MIR221 MIR31 |
12 |
negative regulation of sprouting angiogenesis |
GO:1903671 |
9.72 |
MIR221 MIR18A MIR17 |
13 |
positive regulation of vascular associated smooth muscle cell migration |
GO:1904754 |
9.71 |
MIR221 MIR21 MIR143 |
14 |
negative regulation of cell migration involved in sprouting angiogenesis |
GO:0090051 |
9.71 |
MIR483 MIR221 MIR199A1 MIR15A |
15 |
negative regulation of inflammatory response |
GO:0050728 |
9.7 |
MIR126 MIR142 MIR145 MIR15A MIR199A1 MIR221 |
16 |
negative regulation of transporter activity |
GO:0032410 |
9.69 |
MIR93 MIR9-1 MIR17 |
17 |
angiotensin-activated signaling pathway |
GO:0038166 |
9.65 |
MIR145 MIR143 |
18 |
negative regulation of amyloid precursor protein biosynthetic process |
GO:0042985 |
9.65 |
MIR31 MIR17 MIR144 |
19 |
positive regulation of cardiac muscle hypertrophy in response to stress |
GO:1903244 |
9.64 |
MIR199A1 MIR17 |
20 |
negative regulation of vascular associated smooth muscle cell apoptotic process |
GO:1905460 |
9.63 |
MIR21 MIR17 |
21 |
aorta smooth muscle tissue morphogenesis |
GO:0060414 |
9.63 |
MIR145 MIR143 |
22 |
positive regulation of metalloendopeptidase activity |
GO:1904685 |
9.62 |
MIR21 MIR17 |
23 |
negative regulation of leukocyte adhesion to vascular endothelial cell |
GO:1904995 |
9.61 |
MIR31 MIR221 |
24 |
negative regulation of BMP secretion |
GO:2001285 |
9.6 |
MIR93 MIR17 |
25 |
negative regulation of interleukin-21 production |
GO:0032705 |
9.58 |
MIR21 MIR221 |
26 |
regulation of phenotypic switching |
GO:1900239 |
9.58 |
MIR143 MIR145 |
27 |
positive regulation of pulmonary blood vessel remodeling |
GO:1905111 |
9.57 |
MIR17 MIR143 |
28 |
positive regulation of cellular response to hypoxia |
GO:1900039 |
9.56 |
MIR21 MIR145 |
29 |
negative regulation of vascular endothelial growth factor production |
GO:1904046 |
9.56 |
MIR93 MIR199A1 MIR17 MIR15A |
30 |
establishment or maintenance of cell type involved in phenotypic switching |
GO:0044663 |
9.49 |
MIR145 MIR143 |
31 |
miRNA-mediated gene silencing by inhibition of translation |
GO:0035278 |
9.32 |
MIR126 MIR144 MIR145 MIR15A MIR17 MIR21 |